MARIPOSA: Combination therapy as the new standard of care for EGFR-mutated NSCLC - Medizinonline

… Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitreten Already a member? Log in here...

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Atopic dermatitis and allergies Atopic dermatitis and allergies

Type 2 inflammation and other factors

Diabetes mellitus

Treatment of comorbidities in older people

You May Also Like

8 min

Obesity: More than half of those affected have fatty liver disease

From screening to multimodal intervention with GLP-1-RA or resmetirom

6 min

Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib

First-class immunomodulation combined with convenience—the data available so far is convincing

4 min

Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

6 min

Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

7 min

Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

10 min

Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

7 min

Ischemic stroke: Are smaller or larger brain arteries affected?

Recent study findings on intravenous lysis therapy with fibrinolytic agents

7 min

Interview

“On par with the gold standards for trauma”

Input your search keywords and press Enter.